ClinicalTrials.gov
ClinicalTrials.gov Menu

Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer (LISA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00463489
Recruitment Status : Active, not recruiting
First Posted : April 20, 2007
Last Update Posted : March 23, 2018
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Ontario Clinical Oncology Group (OCOG)